The Board remands the service connection claim for inclusion body myositis to obtain an adequate medical opinion regarding the relationship between the Veteran's condition and potential toxic exposures during service.
The deciding factor: The February 2024 VA TERA medical opinion was found inadequate as it merely listed evidence without providing a reasoned conclusion, thus requiring a remand for a new opinion.
- Claimed conditions
- inclusion body myositis (IBM)
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- March 21, 2025
- Citation
- A25026609
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted service connection for inclusion body myositis, finding that the evidence supports a relationship between the condition and active-duty service.
- Granted
The Board granted service connection for inclusion body myositis (IBM) based on the Veteran's in-service exposure to trichloroethylene (TCE).
- Denied
The Board denied the veteran's claim for service connection for inclusion body myositis, finding that there was no evidence of a link between his condition and in-service exposure to herbicide agents.
- Dismissed
The appeal for service connection for inclusion body myositis (IBM) has been dismissed as moot.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.